KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Other financing activities (2016 - 2025)

Amgen (AMGN) has 17 years of Other financing activities data on record, last reported at $57.0 million in Q4 2025.

  • For Q4 2025, Other financing activities rose 2950.0% year-over-year to $57.0 million; the TTM value through Dec 2025 reached -$52.0 million, up 58.06%, while the annual FY2025 figure was -$52.0 million, 58.06% up from the prior year.
  • Other financing activities reached $57.0 million in Q4 2025 per AMGN's latest filing, up from $10.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $57.0 million in Q4 2025 and bottomed at -$92.0 million in Q2 2025.
  • Average Other financing activities over 5 years is -$21.4 million, with a median of -$26.0 million recorded in 2022.
  • Peak YoY movement for Other financing activities: plummeted 221.43% in 2024, then surged 2950.0% in 2025.
  • A 5-year view of Other financing activities shows it stood at $26.0 million in 2021, then tumbled by 61.54% to $10.0 million in 2022, then crashed by 150.0% to -$5.0 million in 2023, then skyrocketed by 60.0% to -$2.0 million in 2024, then soared by 2950.0% to $57.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other financing activities were $57.0 million in Q4 2025, $10.0 million in Q3 2025, and -$92.0 million in Q2 2025.